Cancer drug prices cut sharply; experts say pricing still too high

The drug price regulator NPPA has released new maximum prices for 543 anti-cancer medicine brands, and the cuts take effect from November 9. A health group says controlling trade margins alone is not enough. It argues that life-saving cancer treatment should be affordable based on medical need.